Integra LifeSciences Holdings Corporation (IART)

NASDAQ: IART · IEX Real-Time Price · USD
32.80
-0.35 (-1.06%)
At close: Apr 12, 2024, 4:00 PM
32.45
-0.35 (-1.07%)
After-hours: Apr 12, 2024, 4:03 PM EDT
-1.06%
Market Cap 2.57B
Revenue (ttm) 1.54B
Net Income (ttm) 67.74M
Shares Out 78.22M
EPS (ttm) 0.84
PE Ratio 39.05
Forward PE 10.09
Dividend n/a
Ex-Dividend Date n/a
Volume 619,744
Open 32.81
Previous Close 33.15
Day's Range 32.50 - 32.92
52-Week Range 32.50 - 59.33
Beta 1.14
Analysts Buy
Price Target 45.00 (+37.2%)
Earnings Date Apr 25, 2024

About IART

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and ins... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Aug 16, 1995
Employees 3,946
Stock Exchange NASDAQ
Ticker Symbol IART
Full Company Profile

Financial Performance

In 2023, IART's revenue was $1.54 billion, a decrease of -1.03% compared to the previous year's $1.56 billion. Earnings were $67.74 million, a decrease of -62.48%.

Financial Statements

Analyst Forecast

According to 9 analysts, the average rating for IART stock is "Buy." The 12-month stock price forecast is $45.0, which is an increase of 37.20% from the latest price.

Price Target
$45.0
(37.20% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Integra LifeSciences Completes the Acquisition of Acclarent, Inc.

PRINCETON, N.J., April 01, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it has successfully completed ...

12 days ago - GlobeNewsWire

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Integra Lifesciences Holdings Corp - IART

NEW YORK , March 25, 2024 /PRNewswire/ -- Pomerantz LLP is investigating whether the Board of Directors of Integra Lifesciences Holdings Corp (NASDAQ: IART) ("Integra") potentially breached their fidu...

19 days ago - PRNewsWire

Integra LifeSciences Launches MicroMatrix® Flex to Provide Convenient Access to Hard-to-Reach Areas in Complex Cases

Novel system features flexible tip to deliver flowable version of the Urinary Bladder Matrix (UBM) technology Novel system features flexible tip to deliver flowable version of the Urinary Bladder Matr...

4 weeks ago - GlobeNewsWire

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In March - Ironwood Pharmaceuticals (NASDAQ:IRWD), Integra Lifesciences (NASDAQ:IART)

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Other symbols: IRWDPACB
5 weeks ago - Benzinga

Integra LifeSciences Announces Leadership Transition Plan

Jan De Witte to retire as CEO by the end of 2024Stuart Essig appointed executive chairman of the Board PRINCETON, N.J., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (“In...

6 weeks ago - GlobeNewsWire

Integra LifeSciences Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance

PRINCETON, N.J., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31, 202...

6 weeks ago - GlobeNewsWire

Integra LifeSciences to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call on February 28, 2024

PRINCETON, N.J., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full year 2023...

2 months ago - GlobeNewsWire

Integra LifeSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference

PRINCETON, N.J., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Jan De Witte, president a...

3 months ago - GlobeNewsWire

Integra LifeSciences Announces Definitive Agreement to Acquire Acclarent®

PRINCETON, N.J., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a global leader in medical technology, today announced that it has entered into a definitiv...

4 months ago - GlobeNewsWire

Integra LifeSciences Appoints Jeff Graves, Ph.D., to Board of Directors

PRINCETON, N.J., Dec. 12, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that Jeff Graves, Ph.D., presi...

4 months ago - GlobeNewsWire

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Integra Investors of a Lead Plaintiff Deadline of November 13, 2023

NEW YORK , Nov. 13, 2023 /PRNewswire/ -- Attention Integra LifeSciences Holdings Corporation ("Integra") (NASDAQ: IART) shareholders: The Law Offices of Vincent Wong announce that a class action lawsu...

5 months ago - PRNewsWire

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART

NEW YORK , Nov. 11, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Integra LifeSciences Holdings Corporation ("Integra" or the "Company") (NASDAQ: IART). Such inv...

5 months ago - PRNewsWire

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Integra LifeSciences Holdings Corporation (IART)

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming November 13, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of inves...

5 months ago - Business Wire

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Integra LifeSciences Holdings Corporation(IART) Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK , Nov. 9, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Integra LifeSciences Holdings Corporation ("Integra" or the "Company") (NASDAQ: IART) of a class action securities l...

5 months ago - PRNewsWire

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Integra LifeSciences Holdings Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 13, 2023 - (NASDAQ: IART)

NEW YORK , Nov. 7, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Integra LifeSciences Holdings Corporation. Shareholders who purchased shares of IART during th...

5 months ago - PRNewsWire

IART Investors Have Opportunity to Lead Integra LifeSciences Holdings Corporation Securities Fraud Lawsuit

BENSALEM, Pa. , Nov. 7, 2023 /PRNewswire/ -- Law Offices of Howard G.

5 months ago - PRNewsWire

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Integra LifeSciences Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - IART

NEW YORK , Nov. 6, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Integra LifeSciences Holdings Corporation (NASDAQ: IART) between M...

5 months ago - PRNewsWire

INTEGRA LIFESCIENCES SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Integra LifeSciences Holdings Corporation - IART

NEW ORLEANS , Nov. 3, 2023 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 13, 2023 to file lead plaintiff applications in a securi...

5 months ago - PRNewsWire

INTEGRA SHAREHOLDER ALERT

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Integra To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Integr...

5 months ago - PRNewsWire

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Integra LifeSciences Holdings Corporation (IART) Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK , Nov. 2, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Integra LifeSciences Holdings Corporation ("Integra" or the "Company") (NASDAQ: IART) of a class action securities l...

5 months ago - PRNewsWire

FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Integra LifeSciences Holdings Corporation - IART

CEDARHURST, N.Y. , Nov. 1, 2023 /PRNewswire/ -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Integra LifeSciences Holdings Corporation (NasdaqGS: IART),...

5 months ago - PRNewsWire

IART INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Integra LifeSciences Holdings Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK--(BUSINESS WIRE)---- $IART #classaction--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been fil...

5 months ago - Business Wire

INTEGRA LIFESCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Integra LifeSciences Holdings Corporation - IART

NEW ORLEANS , Oct. 27, 2023 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until November 1...

6 months ago - PRNewsWire

Integra LifeSciences Reports Third Quarter 2023 Financial Results

PRINCETON, N.J., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the third...

6 months ago - GlobeNewsWire

ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Integra LifeSciences Holdings Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - IART

NEW YORK , Oct. 24, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Integra LifeSciences Holdings Corporation (NASDAQ: IART) between ...

6 months ago - PRNewsWire